These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The proof of drug effects on endocrine glands or endocrine target organs by means of toxicological investigations. Kramer M; Günzel P Pharmacol Ther B; 1979; 5(1-3):287-96. PubMed ID: 493314 [No Abstract] [Full Text] [Related]
4. Adverse endocrinological side effects of new drugs in men. Nieschlag E Pharmacol Ther B; 1979; 5(1-3):407-9. PubMed ID: 493321 [No Abstract] [Full Text] [Related]
5. The weanling male rat as an assay for endocrine disruption: preliminary observations. Ashby J; Lefevre PA Regul Toxicol Pharmacol; 1997 Dec; 26(3):330-7. PubMed ID: 9441923 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological methods in toxicology: general concepts. Zbinden G Pharmacol Ther B; 1979; 5(1-3):3-6. PubMed ID: 386372 [No Abstract] [Full Text] [Related]
7. Biopharmaceutical studies, a key to better toxicology. Zbinden G Xenobiotica; 1988 Jan; 18 Suppl 1():9-14. PubMed ID: 3344592 [No Abstract] [Full Text] [Related]
8. Environmental estrogens and endocrine disruption: importance of comparative endocrinology. Foster WG Endocrinology; 2008 Sep; 149(9):4267-8. PubMed ID: 18511513 [No Abstract] [Full Text] [Related]
10. Polish Society of Endocrinology Position statement on endocrine disrupting chemicals (EDCs). Rutkowska A; Rachoń D; Milewicz A; Ruchała M; Bolanowski M; Jędrzejuk D; Bednarczuk T; Górska M; Hubalewska-Dydejczyk A; Kos-Kudła B; Lewiński A; Zgliczyński W Endokrynol Pol; 2015; 66(3):276-81. PubMed ID: 26136137 [TBL] [Abstract][Full Text] [Related]
11. The importance of protocol design and data reporting to research on endocrine disruption. Ashby J; Odum J Environ Health Perspect; 1998 Jul; 106(7):A315-6; author reply A316-7. PubMed ID: 9734998 [No Abstract] [Full Text] [Related]
13. International Workshop on the Use of Pharmacological Methods in Safety-Evaluation of New Drugs, 1977. Proceedings. Pharmacol Ther B; 1979; 5(1-3):1-605. PubMed ID: 493303 [No Abstract] [Full Text] [Related]
14. From cells to QSAR: Alternative predictive models in toxicology. Sambuy Y; Bassi AM; Scanarotti C; Caloni F ALTEX; 2017; 34(1):168-171. PubMed ID: 28105479 [No Abstract] [Full Text] [Related]
15. Randomization of animals by computer program for toxicity studies. Martin RA; Daly A; DiFonzo CJ; de la Iglesia FA J Environ Pathol Toxicol Oncol; 1986; 6(5-6):143-52. PubMed ID: 3783436 [TBL] [Abstract][Full Text] [Related]
16. Metabolic and kinetic aspects of toxicological studies. 19 May 1987, Paris, France. Xenobiotica; 1988 Jan; 18 Suppl 1():1-96. PubMed ID: 3344587 [No Abstract] [Full Text] [Related]
17. JALA special issue: microengineered cell- and tissue-based assays for drug screening and toxicology applications. Huh DD; Kim DH J Lab Autom; 2015 Apr; 20(2):79-81. PubMed ID: 25795434 [No Abstract] [Full Text] [Related]
18. Embracing complexity in drug discovery. Gund P; Maliski E; Brown F Curr Opin Drug Discov Devel; 2007 May; 10(3):252-3. PubMed ID: 17554850 [No Abstract] [Full Text] [Related]
19. The rat toxicity screen. Fowler JS; Brown JS; Bell HA Pharmacol Ther B; 1979; 5(1-3):461-6. PubMed ID: 493326 [No Abstract] [Full Text] [Related]
20. The principles and practice of toxigenomics: applications and opportunities. Pennie WD; Tugwood JD; Oliver GJ; Kimber I Toxicol Sci; 2000 Apr; 54(2):277-83. PubMed ID: 10774809 [No Abstract] [Full Text] [Related] [Next] [New Search]